EUVIMEDEUVIMED entdecken
Crossref

The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia

Lance A Williams iD, Jill Adamski, Theresa N Kinard, Natalie M Ertz-Archambault, Qun Lu, Kristin Gray, Jennifer L Herrick, Leon Su, Leslie Padrnos

Journal of Clinical Apheresis · 2023-12 · 38 (6) · 755-759

DOI: 10.1002/jca.22086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Apheresis, online erschienen am 04.09.2023. Verfasst von Lance A Williams und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic Hospital, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Methemoglobinemia, Hemoglobins, Abnormal, Anemia, Sickle Cell. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This manuscript describes a novel approach for treating patients with long‐term sequelae from hemoglobin Evans (Hb Evans). After instituting conservative therapies for approximately 2 years, our patient's symptoms continually worsened. Therefore, we performed red blood cell exchange (RBCx) to reduce his Hb Evans percentage and his co‐existing elevation of methemoglobin. Our assumptions of clinical benefit were based on our collective experience performing RBCx for patients with sickle cell disease. After the first exchange, pre‐ and post‐laboratory results supported our approach and the patient experienced marked improvement in his clinical signs and symptoms. This report provides preliminary proof of principle for the use of RBCx to treat Hb Evans and other non‐Hb S hemoglobinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethemoglobinemiaHemoglobins, AbnormalAnemia, Sickle CellHumansErythrocytes

Stichwörter der Autor:innen

hemoglobin Evanshemoglobinopathymethemoglobinred blood cell exchange (RBCx)unstable hemoglobin

Substanzen

hemoglobin EvansHemoglobins, Abnormal

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic Hospital, Phoenix, Arizona, USA.
  • Department of Hematology/Oncology, Valleywise Comprehensive Healthcare Center, Phoenix, Arizona, USA.
  • Department of Laboratory Medicine and Pathology (Hematopathology), Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Hematology/Oncology, Mayo Clinic Hospital, Phoenix, Arizona, USA.

ORCID-Profile: Lance A Williams

Zitieren

APA

Williams, L. A., Adamski, J., Kinard, T. N., Ertz-Archambault, N. M., Lu, Q., Gray, K., Herrick, J. L., Su, L., & Padrnos, L. (2023). The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia. Journal of Clinical Apheresis, 38(6), 755-759. https://doi.org/10.1002/jca.22086

Vancouver

Williams LA, Adamski J, Kinard TN, Ertz-Archambault NM, Lu Q, Gray K, et al. The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia. Journal of Clinical Apheresis. 2023;38(6):755-759. doi:10.1002/jca.22086

BibTeX
@article{Williams2023,
  author = {Williams, Lance A and Adamski, Jill and Kinard, Theresa N and Ertz-Archambault, Natalie M and Lu, Qun and Gray, Kristin and Herrick, Jennifer L and Su, Leon and Padrnos, Leslie},
  title = {The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia},
  journal = {Journal of Clinical Apheresis},
  year = {2023},
  volume = {38},
  number = {6},
  pages = {755--759},
  doi = {10.1002/jca.22086}
}
Kostenlos starten →